Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
13 December, 2017 22:19 IST
Zydus Cadila gets USFDAs final nod for Desvenlafaxine ER tablets
Source: IRIS | 12 Oct, 2017, 01.10PM
Comments  |  Post Comment

Zydus Cadila has received the final approval from the U.S. Food & Drug Administration (USFDA) to market Desvenlafaxine Extended-Release Tablets, 50 mg and 100 mg. The drug is used to treat major depression and will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad.

The group now has more than 160 approvals and has so far filed over 300 ANDAs since the commencement of the filing process in FY 2003-04.

Total volume of shares traded on the bourses today was lower by 52.05% to 600,531 compared with 22-day average volume of 1,252,527.

Shares of the company gained Rs 8.65, or 1.76%, to trade at Rs 500.00. The total volume of shares traded was 34,356 at the BSE (12.58 p.m., Thursday).



Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Bharti Airtel sells 20% stake in DTH arm to Warburg Pincus - 13-Dec-2017 11:24
Seamec enters into contract with Dolphin Offshore for 'SEAMEC III' - 13-Dec-2017 11:13
IRIS Business Services to implement SIS for Nepal Rastra Bank - 13-Dec-2017 10:23
Asian Paints acquires 100% stake in Reno for Rs 1.59 bn - 13-Dec-2017 10:18
Punj Lloyd wins orders worth Rs 14.53 bn from GAIL, NHAI - 13-Dec-2017 10:14
JB Chemicals receives USFDA nod for Atenolol tablets - 13-Dec-2017 10:08
Kalpataru Power bags new orders worth Rs 8.75 bn - 13-Dec-2017 10:05
Ramco Systems wins order from SUEZ Middle East Water Services - 12-Dec-2017 15:22
BHEL commissions coal-fired power project in Indonesia - 12-Dec-2017 15:14
Alembic Pharma gets USFDA's nod for Darifenacin tablets - 12-Dec-2017 11:58
Sadbhav Infra emerges lowest bidder for Dangiywas-ajiwal project - 12-Dec-2017 10:43
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer